Publisher
Springer International Publishing
Reference85 articles.
1. Lisman T, Porte RJ. Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases. Res Pract Thromb Haemost. 2017;1:150–61.
2. Ferro D, Basili S, Lattuada A, Mantovani B, Bellomo A, Mannucci PM, et al. Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation. Ital J Gastroenterol Hepatol. 1997 Oct;29(5):434–40.
3. Sullivan BP, Kopec AK, Joshi N, Cline H, Brown JA, Bishop SC, et al. Hepatocyte tissue factor activates the coagulation cascade in mice. Blood. 2013 Mar 7;121(10):1868–74.
4. Rautou PE, Tatsumi K, Antoniak S, Owens AP, Sparkenbaugh E, Holle LA, et al. Hepatocyte tissue factor contributes to the hypercoagulable state in a mouse model of chronic liver injury. J Hepatol. 2016 Jan;64(1):53–9.
5. Lisman T, Porte RJ. Value of preoperative hemostasis testing in patients with liver disease for perioperative hemostatic management. Anesthesiology. 2017 Dec 2;126(2):338–44.